Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 18/20 | 0.49 |
| ▸ | ITGA2B | P08514 | 18/20 | 0.49 |
| ▸ | F2R | P25116 | 11/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7439765 | 0.88 | ITGB3 (0.51) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL7443492 | 0.85 | KMT2A (0.41) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL7441383 | 0.85 | ITGB3 (0.51) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL6539873 | 0.84 | ITGB3 (0.52) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL7445041 | 0.83 | ITGB3 (0.48) | ITGB3ITGA2BF2RKMT2ASMN1; SMN2 | |
| Trifluoroacetic Acid SCHEMBL7451108 | 0.83 | ITGB3 (0.47) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL7432848 | 0.83 | ITGB3 (0.51) | ITGB3ITGA2BF2RKMT2A | |
| SCHEMBL6538748 | 0.82 | ITGB3 (0.51) | ITGB3ITGA2BF2R | |
| SCHEMBL14426998 | 0.82 | ITGB3 (0.51) | ITGB3ITGA2BF2R | |
| SCHEMBL7439975 | 0.82 | ITGB3 (0.51) | ITGB3ITGA2BF2RKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384028-B1 | TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| WO-1996029309-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-26 | — | — | WO | disclosed |